It has been previously shown that vasoactive intestinal polypeptide (VIP) induces endothelium-dependent relaxation of the human uterine artery. However, the nature of the mediator of the VIP-induced endotheliumdependent relaxation of the human uterine artery has not yet been determined. Therefore these experiments were undertaken to examine the effects of VIP on human uterine arteries and to establish the role of various endothelial factors on the relaxation induced by VIP. The experiments were performed on isolated human uterine arterial rings. VIP (0.3-100 nM) induced a concentration-dependent relaxation of human uterine arteries with intact endothelium (pEC 50 ⍧ 8.06 ⍨ 0.14, n ⍧ 28). After the removal of the endothelium this relaxation was abolished (n ⍧ 6). Indomethacin (10 µM), a cyclooxygenase inhibitor, and diethylcarbamazine (100 µM), a lipoxygenase blocker, had no effects on VIP-induced relaxation. In contrast, methylene blue (10 µM), a blocker of guanylate cyclase, N G -monomethyl-L-arginine (10 µM), an inhibitor of nitric oxide (NO) synthase, and 4-aminopyridine (1 mM), a non-selective blocker of K ⍣ channels, antagonized the effect of VIP with suppression of maximal VIP-induced relaxation. Non-competitive antagonism with methylene blue revealed that the pKa value for VIP-receptor complex was 8.10 ⍨ 0.10 (n ⍧ 6) and the receptor reserve expressed as K A /EC 50 was 0.89 ⍨ 0.11, where pKa ⍧ log 10 K A , and K A is the dissociation constant of VIPreceptor complex. Therefore, on the basis of the results presented, we can conclude that VIP induces endothelium-dependent relaxation in human uterine arteries, acting as a partial agonist on this blood vessel. It appears that endothelium-dependent relaxation induced by VIP in human uterine artery can be entirely explained by the release of NO from endothelial cells.
Introduction
It has been reported that vasoactive intestinal polypeptide (VIP) is a vasodilator in different blood vessels (Davies and Williams, 1983; Bakken et al., 1995) . However, the role of vascular endothelium in VIP-induced relaxation has been shown to vary in different vascular tissues, depending upon the anatomical location and species. For example, in human, bovine, rat and rabbit pulmonary artery and in the pig coronary artery, VIP induces endothelium-independent relaxation (Barnes et al., 1986; Beny et al., 1986; Sata et al., 1986; Greenberg et al., 1987) , while in the rat aorta, rat mesenteric artery and porcine ophthalmic artery endothelium-dependent relaxation evoked by VIP has been observed (Davies and Williams, 1983; Hattori et al., 1992; Bakken et al., 1995) .
It is known that uterine blood flow is regulated by diverse neuronal and humoral factors (Ekesbo et al., 1991; Jovanović et al., 1994b Jovanović et al., , 1995b . It has been proposed that, besides acetylcholine and noradrenaline (Jovanović et al., 1994a (Jovanović et al., -d, 1995b , VIP is one of the most important neuronal factors in regulation of uterine blood flow in humans (Ekesbo et al., 1991) . However, the effect of this peptide on human uterine artery is still controversial. For example, Ekesbo et al. (1991) reported that VIP produces inconsistent relaxation of human uterine artery, while Bodelsson and Stjernquist (1992) suggested an endothelium-dependent relaxation of this artery induced by VIP. In general, endothelial cells can produce potent dilators of certain blood vessels: nitric oxide (NO), endothelium-derived hyperpolarizing factor (EDHF), prostacyclin and other products of arachidonic acid metabolism (reviewed by Vane et al., 1990) . In this regard, it has been shown that endothelium-dependent relaxation of uterine artery, induced by acetylcholine, is mediated solely through endothelial production of NO synthesized from L-arginine in the vascular endothelial cells (Jovanović et al., 1994c (Jovanović et al., , 1995a (Jovanović et al., , 1997a . However, the nature of the mediator of the VIPinduced endothelium-dependent relaxation of human uterine arteries is still unknown.
Therefore, the present experiments were undertaken in order to examine the effects of VIP on human uterine arteries, and to establish the role of various endothelial factors on the relaxation produced by VIP.
Materials and methods
Human uterine arteries were obtained from 14 non-pregnant women (mean age Ϯ SEM, 43.0 Ϯ 4.2, range 28-56) undergoing hysterectomy for benign gynaecological diseases (adenomyosis, endometriosis, fibromyoma). No patients with malignant disease or receiving radiological, cytotoxic or antihypertensive therapy were included. During surgery, the patients received anaesthesia with a combination of nitrous oxide, oxygen, thiopentone and fentanyl. Muscle relaxation was induced by suxamethonium and maintained by pancuronium. The vessels were excised within 10 min of clamping the blood flow and placed in cold (ϩ4°C) Krebs-Ringer bicarbonate solution. The patients were informed in detail about the purpose of the investigation and had given their consent to the excision of the preparations. After excision, the vessels were immediately transported to the laboratory.
The uterine arteries were dissected free from connective tissue. They were cut into 4 mm rings. Care was taken not to damage the endothelium unintentionally. In some rings, the endothelium was removed mechanically by gently rubbing the intimal surface with a stainless steel wire (Jovanović et al., 1994b) . Ring preparations were mounted between two stainless steel triangles in an organ chamber containing 15 ml Krebs-Ringer bicarbonate solution (37°C, pH 7.4), aerated with 95% O 2 and 5% CO 2 . One of the triangles was attached to a displacement unit allowing the fine adjustment of tension and the other was connected to a force-displacement transducer (Hugo Sachs K30). Isometric tension was recorded on a Hugo Sachs model MC 6621 recorder.
Preparations were allowed to equilibrate for about 1 h in KrebsRinger bicarbonate solution. During this period the organ baths were washed with fresh (37°C) buffer solution every 15 min.
After 60 min, each ring was gradually stretched to the optimal point of its tension (28 mN, Jovanović et al., 1994c, d ). Once at their optimal length, the segments were allowed to equilibrate for 30 min before experimentation.
At the beginning of each experiment the vessel segment was exposed twice to a K ϩ -rich Krebs-Ringer bicarbonate solution (126 mM KCl, achieved by exchanging the 118.3 mM NaCl with KCl). Only if the second contractile response to K ϩ was equivalent in magnitude to the first (variation less than 10%) was the preparation used for further experimentation. Subsequently, in order to confirm the presence or successful denudation of endothelium, the rings precontracted with phenylephrine (10 µM) were challenged with acetylcholine (10 µM). On the basis of prior studies (Jovanović et al., 1994c, e) , relaxation greater than 50% or less than 20% of maximal relaxation evoked by acetylcholine (maximal relaxation represented complete return to the resting tension from the contraction in response to phenylephrine) was indicative of structurally intact or denuded endothelium respectively, regardless of pregnancy status. Additionally, at the end of some experiments (10 of each), the condition of the endothelium was verified by Van Gieson's staining with an iron haematoxylin counterstain and followed by light microscopic examination of the intimal surface (Disbrey and Rack, 1970) .
Concentration-response curves were obtained by cumulative addition of VIP to ring segments contracted to a stable plateau by adding 10 µM phenylephrine. Experiments followed a multiple curve design since separate experiments (n ϭ 4) demonstrated that first and second concentration-response curves for VIP were not significantly different. Therefore, the following protocol was used: (i) contraction in response to K ϩ -rich Krebs-Ringer bicarbonate solution followed by three washes and a 30 min equilibration period; (ii) contraction in response to K ϩ -rich Krebs-Ringer bicarbonate solution followed by three washes and a 30 min equilibration period; (iii) contraction in response to phenylephrine, addition of acetylcholine, followed by three washes 72 and 30 min equilibration period; (iv) contraction in response to phenylephrine and concentration-response curve with VIP, followed by three washes, addition of the antagonists and a 15 (methylene blue, N G -monomethyl-L-arginine), 20 (4-aminopyridine), 30 (diethylcarbamazine) or 40 (indomethacin) min equilibration period; and (v) contraction in response to phenylephrine and the concentration-response curve with VIP.
At the end of each experiment papaverine (300 µM) was added to the organ bath to determine the maximal relaxation of preparations.
Treatment of data and statistics
The relaxation induced by each concentration of VIP was expressed as a percentage of the maximum relaxation to papaverine and used in the construction of the concentration-response curves. The concentration of VIP eliciting 50% of its own maximum response (EC 50 ) was determined graphically for each curve by linear interpolation. EC 50 value was presented as pEC 50 (pEC 50 ϭ -log EC 50 ).
VIP dissociation constant (K A ) was calculated according to the method of Kenakin (1987) , using methylene blue as a non-competitive antagonist (Jovanović et al., 1994d) 
Estimates of the receptor reserve were made from K A /EC 50 (Kenakin, 1987) .
The results are expressed as means Ϯ SEM; n refers to the number of experiments. Statistical differences between two means were determined by Student's t-test for paired or unpaired observations where appropriate. The least squares method was used for calculating linear regressions. A value of P Ͻ 0.05 was considered to be statistically significant.
Drugs and solutions
The Krebs-Ringer-bicarbonate solution had the following composition (in mmol/l): NaCl 118.3; KCl 4.7; CaCl 2 2.5; MgSO 4 1.2; KH 2 PO 4 1.2; NaHCO 3 25.0; CaEDTA 0.026; glucose 11.1. The solution was continuously bubbled with 95% O 2 and 5% CO 2 resulting in a pH of 7.4, and temperature was kept at ϩ37°C. The following drugs were used: acetylcholine chloride, indomethacin, diethylcarbamazine, 4-aminopyridine (4-AP), L-phenylephrine (Sigma, St Louis, MO, USA); L-N G monomethyl-L-arginine (L-NMMA) acetate (Wellcome, London, UK), methylene blue (Kemika, Zagreb, Croatia), papaverine hydrochloride (Merck, Rashway, NJ, USA). All drugs were prepared immediately before the experiment and stored on ice until used. All agents were dissolved in distilled water and diluted to the desired concentration with buffer. The only exception was indomethacin, which was dissolved in equimolar Na 2 CO 3 solution. All drugs were added directly to the bath in volume of 150 µl and the concentrations given are the calculated final concentrations in the bath solution. When potassium chloride was used as a spasmogen, the stated concentration excludes the potassium chloride (4.7 mmol/ l) already present in the Krebs-Ringer bicarbonate solution.
Results

Effect of VIP
VIP (0.3-100 nM) induced a concentration-dependent relaxation of precontracted human uterine arterial rings (pEC 50 ϭ 8.06 Ϯ 0.14, maximal response ϭ 83.1 Ϯ 4.3%, n ϭ 28) with 
Effects of indomethacin and diethylcarbamazine
The administration of the cyclooxygenase inhibitor, indomethacin (10 µM) and a lipoxygenase blocker, diethylcarbamazine (100 µM), did not modify the relaxation induced by VIP (Figure 2 ).
Effects of methylene blue and L-NMMA
Methylene blue (10 µM) and L-NMMA (10 µM) significantly induced a dextral shift of VIP concentration-response curve and suppressed a maximal response (Figure 3 ).
Effect of 4-AP
The relaxation of the human uterine artery induced by VIP was almost completely abolished after the administration of 4-AP (Figure 4 ).
Dissociation constant of the VIP-receptor complex
In order to determine dissociation constant of the VIP-receptor complex, we used the procedure described by Kenakin (1987) . Methylene blue (10 µM) caused non-competitive inhibition of VIP-induced relaxation as shown by depression of the maximum response (84 Ϯ 4% vs 26.9 Ϯ 3.8%, n ϭ 6, P Ͻ 0.01). The results of these experiments are presented in Figure 5 . The mean pKa value was 8.10 Ϯ 0.10 (n ϭ 6). The receptor reserve expressed as K A /EC 50 was 0.89 Ϯ 0.11.
Discussion
In this study, VIP induced endothelium-dependent relaxation of the human uterine artery, which is in agreement with the previous findings of Bodelsson and Stjernquist (1992) .
Endothelium-dependent vasodilatation mediated by cyclooxygenase products has been observed in different arteries (Toda, 1984; Ortiz et al., 1992) . Moreover, in some blood vessels, it has been shown that prostacyclin is released from endothelial cells after stimulation with certain agonists (Rubanyi et al., 1986) . In addition, in pregnant, but not in non-pregnant, guinea-pig uterine arteries prostaglandin F 2α -induced production of vasodilating prostanoids from vascular endothelium has been shown Jovanović, 1996, 1997) . Ignarro et al. (1987) reported the involvement of prostacyclin in VIP-induced endothelium-dependent vasorelaxation. In the present study, the blockade of cyclooxygenase with indomethacin did not modify the effects of VIP, thus excluding a role for prostanoid production in relaxation evoked by this peptide.
It has been suggested that the lipoxygenase pathway may be involved in the mediation of endothelium-dependent relaxation of different arteries, including canine uterine artery (Uotila et al., 1987; Matsumoto et al., 1992) . In this study, diethylcarbamazine, used in a concentration that inhibits lipoxygenase products of arachidonic acid (Mathews and Murphy, 1982) , did not affect the relaxant effects of VIP on preparations studied. Therefore, this finding does not suggest that lipoxygen- ase cascade products of arachidonic acid are involved in the mediation of this VIP effect.
In 1980 it was reported that acetylcholine dilated certain blood vessels by releasing a non-prostanoid diffusible substance from the endothelium, which was designated endotheliumderived relaxing factor (EDRF) (Furchgott and Zawadzki, 1980) . It has been also reported that several other vasoactive substances, such as histamine, bradykinin, substance P and nucleotides, have been found to act through the release of EDRF and to elicit endothelium-dependent vasodilation (reviewed by Anggard, 1994) . EDRF is believed to be either NO or a labile nitroso compound synthesized from the terminal guanidine nitrogen atom of the amino acid L-arginine in the vascular endothelial cells, probably followed by the metabolism of L-arginine to citrulline (Palmer et al., 1987 (Palmer et al., , 1988 . NO causes relaxation by stimulation of soluble guanylate cyclase, with a consequent rise in the intracellular levels of cyclic 3Ј, 5Ј-guanosine monophosphate (cGMP) (Rapaport and Murad, 1983) . Methylene blue was originally thought to inhibit the action of NO by oxidizing the haem moiety of soluble guanylate cyclase (Martin et al., 1985) . More recently, it has been shown that methylene blue also interferes with NO action by the generation of superoxide (Marczin et al., 1992) , or even directly by inhibiting NO synthase (Mayer et al., 1993; Shimazu et al., 1993) . Consequently, the inhibitory action of methylene blue on the VIP-induced relaxation of human uterine artery allowed the supposition that the vasodilatation in response to VIP in this vessel is possibly mediated by endothelial NO formation. To analyse this possibility further, the inhibitor of NO synthesis, L-NMMA (Palmer et al., 1988 , Rees et al., 1989 , was tested. L-NMMA antagonized the effects of VIP on uterine arteries, confirming the hypothesis that endothelial NO production is involved in the VIP-induced relaxation in human uterine arteries, as has been described in some other blood vessels (Davies and Williams, 1983; Hattori et al., 1992) .
It has been shown that some agonists release a factor from the endothelium of some blood vessels independent of NO (Chen et al., 1988 (Chen et al., , 1991 , which hyperpolarizes vascular smooth muscle (Chen et al., 1988) . This was named endothelium-derived hyperpolarizing factor (EDHF). Moreover, in guinea-pig uterine artery hyperpolarization produced by NO itself has been reported (Tare et al., 1990) , although this finding has been recently contested (Jovanović et al., 1995a (Jovanović et al., , 1997a . The mechanism proposed for the endothelium-dependent hyperpolarization is the increase of potassium conductance by the opening of potassium channels (Chen et al., 1988 (Chen et al., , 1991 Tare et al., 1990) . In order to analyse the contribution of this mechanism to the VIP-induced relaxation in human uterine artery we used 4-AP, a non-selective potassium channel blocker (Cook and Quast, 1990) . Moreover, 4-AP inhibiting hyperpolarization of human uterine arterial smooth muscle has already been described (Jovanović et al., 1994a) . Indeed, 4-AP abolished VIP-induced relaxation suggesting that hyperpolarization is involved in this VIP action. Thus, this result suggests one of the following possibilities: (i) that EDHF is involved in VIP action; (ii) that NO itself hyperpolarizes vascular smooth muscle; and (iii) that VIP-induced opening of K ϩ channels is involved in a step of the transduction pathway which is not related to the production of endothelium-derived relaxing factors. The first two possibilities are rather unlikely, since it has been demonstrated that acetylcholine-induced endotheliumdependent relaxation of human uterine arteries, which is similar to VIP-induced relaxation mediated by NO, is not accompanied by smooth muscle hyperpolarization (Jovanović et al., 1994c) . Also, the finding that 4-AP completely abolished the relaxation induced by VIP, as opposed to L-NMMA, is in accord with the conclusion that neither EDHF or NO-induced hyperpolarization is involved in this VIP action. The most probable hypothesis is that the blockade of K ϩ channels linked to VIP receptors in vascular endothelium (Pasyk et al., 1992 (Pasyk et al., , 1996 is responsible for the inhibitory action of 4-AP on endotheliumdependent relaxation of human uterine artery induced by VIP.
Non-competitive antagonism with L-NMMA revealed that the K A value for VIP-receptor complex was 7.9 nM. This value is within the range reported for VIP-receptor complexes in other tissues (Dehaye et al., 1985; Rodriguez-Henche et al., 1994) , including vascular endothelium (Pasyk et al., 1992) . The receptor reserve for VIP in human uterine arteries was not significantly different from unity, indicating that in this 75 vessel VIP, in common with the other neuropeptide, oxytocin (Jovanović et al., 1997b) , acts as a partial agonist (Kenakin, 1987) . However, as opposed to oxytocin, the maximal effect of VIP was near to the maximum possible relaxation (induced by high concentration of papaverine), which is atypical for a partial agonist action. This finding could be explained by high affinity of VIP for its receptors and, probably, high receptor density, which allows VIP to evoke maximal relaxation, regardless of its low intrinsic activity.
Therefore, on the basis of these results, we can conclude that VIP induces endothelium-dependent relaxation in the human uterine artery, acting as a partial agonist on this blood vessel. It appears that endothelium-dependent relaxation induced by VIP in human uterine arteries can be explained by the release of NO from endothelial cells.
